Cargando…
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas
Diffuse gliomas are the most common type of primary brain and central nervous system (CNS) tumors. Protein disulfide isomerases (PDIs) such as P4HB and PDIA3 act as molecular chaperones for reconstructing misfolded proteins, and are involved in endoplasmic reticulum stress and the unfolded protein r...
Autores principales: | Zou, Hecun, Wen, Chunjie, Peng, Zhigang, Shao, Ying-Ying, Hu, Lei, Li, Shuang, Li, Cuilin, Zhou, Hong-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783617/ https://www.ncbi.nlm.nih.gov/pubmed/29207176 http://dx.doi.org/10.3892/or.2017.6134 |
Ejemplares similares
-
Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas
por: Li, Shuang, et al.
Publicado: (2017) -
lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients
por: Zou, Hecun, et al.
Publicado: (2017) -
PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021) -
REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in glioma
por: Li, Cuilin, et al.
Publicado: (2018) -
PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)